AbbVie Inc. Contracts & Agreements

Underwriting Agreement, dated February 22, 2024, by and among AbbVie Inc., Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC, BofA Securities, Inc. and Citigroup Global Markets... (Filed With SEC on February 26, 2024)

Supplemental Indenture No. 10, dated February 26, 2024, between AbbVie Inc. and U.S. Bank Trust Company, National Association, as trustee (Filed With SEC on February 26, 2024)

Form of 4.800% Note due 2027 (included in Exhibit 4.2 of this Current Report on Form 8-K) (Filed With SEC on February 26, 2024)

Form of 4.800 Note due 2029 (included in Exhibit 4.2 of this Current Report on Form 8-K) (Filed With SEC on February 26, 2024)

Form of 4.950% Note due 2031 (included in Exhibit 4.2 of this Current Report on Form 8-K) (Filed With SEC on February 26, 2024)

Form of 5.050% Note due 2034 (included in Exhibit 4.2 of this Current Report on Form 8-K) (Filed With SEC on February 26, 2024)

Form of 5.350% Note due 2044 (included in Exhibit 4.2 of this Current Report on Form 8-K) (Filed With SEC on February 26, 2024)

Form of 5.400% Note due 2054 (included in Exhibit 4.2 of this Current Report on Form 8-K) (Filed With SEC on February 26, 2024)

Form of 5.500% Note due 2064 (included in Exhibit 4.2 of this Current Report on Form 8-K) (Filed With SEC on February 26, 2024)

Description of the companys securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 20, 2024)

Second Amended and Restated Revolving Credit Agreement, dated as of March 28, 2023, among AbbVie, the lenders and other parties party thereto and JPMorgan Chase Bank, N.A., as... (Filed With SEC on March 28, 2023)

Form of Agreement Regarding Change in Control by and between AbbVie Inc. and its named executive officers (Filed With SEC on October 14, 2022)

AbbVie Non-Employee Directors Fee Plan, as amended and restated (Filed With SEC on August 4, 2022)

Form of AbbVie Inc. Performance-Vested Restricted Stock Unit Agreement (Filed With SEC on May 6, 2022)

Form of AbbVie Inc. Performance Share Award Agreement (Filed With SEC on May 6, 2022)

Form of AbbVie Inc. Non-Employee Director RSU Agreement (US) (Filed With SEC on May 6, 2022)

Form of AbbVie Inc. Non-Qualified Stock Option Agreement (Filed With SEC on May 6, 2022)

Form of AbbVie Inc. Retention RSU Agreement Ratable Vesting (Filed With SEC on May 6, 2022)

Form of AbbVie Inc. Retention RSU Agreement Cliff Vesting with Dividend Equivalent Accrual (Filed With SEC on May 6, 2022)

Description of the companys securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 18, 2022)

AbbVie Performance Incentive Plan, as amended and restated (Filed With SEC on February 18, 2022)

AbbVie Supplemental Pension Plan, as amended and restated (Filed With SEC on February 18, 2022)

AbbVie Supplemental Savings Plan, as amended and restated (Filed With SEC on February 18, 2022)

Description of the companys securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on May 7, 2021)

Form of AbbVie Inc. Performance-Vested Restricted Stock Unit Agreement (Filed With SEC on May 7, 2021)

Form of AbbVie Inc. Performance Share Award Agreement (Filed With SEC on May 7, 2021)

Form of AbbVie Inc. Non-Employee Director RSU Agreement (US) (Filed With SEC on May 7, 2021)

Form of AbbVie Inc. Non-Qualified Stock Option Agreement (Filed With SEC on May 7, 2021)

Form of AbbVie Inc. Retention RSU Agreement - Ratable Vesting (Filed With SEC on May 7, 2021)

Description of the companys securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 19, 2021)

Supplemental Indenture No. 8, dated May 14, 2020, by and between AbbVie Inc. and U.S. Bank National Association, as trustee (Filed With SEC on May 14, 2020)

Supplemental Indenture No. 9, dated May 14, 2020, among AbbVie Inc., U.S. Bank National Association, as trustee, transfer agent and registrar, and Elavon Financial Services DAC,... (Filed With SEC on May 14, 2020)

Agency Agreement, dated May 14, 2020, among AbbVie Inc., U.S. Bank National Association, as trustee, transfer agent and registrar, and Elavon Financial Services DAC, U.K. Branch,... (Filed With SEC on May 14, 2020)

Registration Rights Agreement, dated May 14, 2020, among AbbVie Inc. and Morgan Stanley & Co. LLC, BofA Securities, Inc., Citigroup Global Markets Inc., BNP Paribas Securities... (Filed With SEC on May 14, 2020)

Amendment to the Transaction Agreement, dated as of May 5, 2020, between AbbVie Inc., Allergan plc and Venice Subsidiary, LLC (Filed With SEC on May 8, 2020)

Form of AbbVie Inc. Performance-Vested Restricted Stock Unit Agreement (Filed With SEC on May 8, 2020)

Form of AbbVie Inc. Performance Share Award Agreement (Filed With SEC on May 8, 2020)

Form of AbbVie Inc. Non-Employee Director RSU Agreement (US) (Filed With SEC on May 8, 2020)

Form of AbbVie Inc. Non-Qualified Stock Option Agreement (Filed With SEC on May 8, 2020)

Form of AbbVie Inc. Retention RSU Agreement - Ratable Vesting (Filed With SEC on May 8, 2020)

AbbVie Non-Employee Directors' Fee Plan, as amended and restated (Filed With SEC on May 8, 2020)

Description of the companys securities registered pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 21, 2020)

Purchase Agreement, dated November 12, 2019, among AbbVie Inc. and Morgan Stanley & Co. LLC, BofA Securities, Inc. and Barclays Capital Inc. (acting for themselves and as... (Filed With SEC on November 13, 2019)

AbbVie Non-Employee Directors' Fee Plan, as amended and restated (Filed With SEC on November 6, 2019)

Supplemental Indenture No. 6, dated September 26, 2019, among AbbVie Inc., U.S. Bank National Association, as trustee, transfer agent and registrar, and Elavon Financial Services... (Filed With SEC on September 26, 2019)

Agency Agreement, dated September 26, 2019, among AbbVie Inc., U.S. Bank National Association, as trustee, transfer agent and registrar, and Elavon Financial Services DAC, UK... (Filed With SEC on September 26, 2019)

Underwriting Agreement, dated September 17, 2019, among AbbVie Inc. and Morgan Stanley & Co. International plc, HSBC Bank plc and Merrill Lynch International (acting for... (Filed With SEC on September 23, 2019)

Amended and Restated Revolving Credit Agreement, dated as of August 27, 2019, among AbbVie, the lenders and other parties party thereto and JPMorgan Chase Bank, N.A., as... (Filed With SEC on August 30, 2019)

AbbVie Supplemental Pension Plan, as amended and restated (Filed With SEC on August 5, 2019)

AbbVie 2013 Incentive Stock Program Second Amendment (Filed With SEC on August 5, 2019)

364-Day Term Loan Credit Agreement, dated as of July 12, 2019, among AbbVie, certain lenders party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent (Filed With SEC on July 16, 2019)

First Amendment to Revolving Credit Agreement, dated as of July 12, 2019, among AbbVie, the lenders and other parties party thereto and JPMorgan Chase Bank, N.A., as... (Filed With SEC on July 16, 2019)

Appendix III to the Rule 2.5 Announcement, dated as of June 25, 2019 (Conditions Appendix) (Filed With SEC on June 25, 2019)

Expenses Reimbursement Agreement, dated as of June 25, 2019, between AbbVie and Allergan (Filed With SEC on June 25, 2019)

Transaction Agreement, dated as of June 25, 2019, between AbbVie, Allergan and Acquirer Sub (Filed With SEC on June 25, 2019)

364-Day Bridge Credit Agreement, dated as of June 25, 2019, among AbbVie, Morgan Stanley Senior Funding, Inc. and the lenders party thereto (Filed With SEC on June 25, 2019)

Form of AbbVie Inc. Performance-Vested Restricted Stock Unit Agreement (Filed With SEC on May 3, 2019)

Form of AbbVie Inc. Performance Share Award Agreement (Filed With SEC on May 3, 2019)

Form of AbbVie Inc. Non-Employee Director RSU Agreement (US) (Filed With SEC on May 3, 2019)

Form of AbbVie Inc. Non-Qualified Stock Option Agreement (Filed With SEC on May 3, 2019)

Form of AbbVie Inc. Non-Employee Director Non-Qualified Stock Option Agreement (Filed With SEC on May 3, 2019)

Underwriting Agreement, dated September 13, 2018, by and among AbbVie Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated, J.P. Morgan Securities LLC, Morgan Stanley & Co.... (Filed With SEC on September 18, 2018)

Supplemental Indenture No. 5, dated September 18, 2018, between AbbVie Inc. and U.S. Bank National Association, as trustee (Filed With SEC on September 18, 2018)

Revolving Credit Agreement, dated as of August 31, 2018, among AbbVie, the lenders and other parties party thereto, and JPMorgan Chase Bank, N.A., as administrative agent (Filed With SEC on September 6, 2018)

First Amendment to 364-Day Term Loan Credit Agreement, dated as of August 31, 2018, among AbbVie, the lenders and other parties party thereto, and Bank of America, N.A., as... (Filed With SEC on September 6, 2018)

364-Day Term Loan Credit Agreement, dated as of May 17, 2018, among AbbVie, the lenders and other parties party thereto, and Bank of America, N.A., as administrative agent (Filed With SEC on May 18, 2018)

Form of AbbVie Inc. Performance-Vested Restricted Stock Unit Agreement (Filed With SEC on May 4, 2018)

Form of AbbVie Inc. Performance Share Award Agreement (Filed With SEC on May 4, 2018)

Form of AbbVie Inc. Non-Employee Director RSU Agreement (US) (Filed With SEC on May 4, 2018)

Form of AbbVie Inc. Non-Qualified Stock Option Agreement (Filed With SEC on May 4, 2018)

Form of AbbVie Inc. Non-Employee Director Non-Qualified Stock Option Agreement (Filed With SEC on May 4, 2018)

Form of AbbVie Inc. Performance Share Award Agreement (Filed With SEC on February 16, 2018)

AbbVie Non-Employee Directors' Fee Plan, as amended and restated (Filed With SEC on February 16, 2018)

ABBVIE INC. NON-EMPLOYEE DIRECTOR RESTRICTED STOCK UNIT AGREEMENT (Filed With SEC on May 5, 2017)

ABBVIE INC. NON-QUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on May 5, 2017)

ABBVIE INC. PERFORMANCE SHARE AWARD AGREEMENT (Filed With SEC on May 5, 2017)

ABBVIE INC. PERFORMANCE-VESTED RESTRICTED STOCK UNIT AGREEMENT (Filed With SEC on May 5, 2017)

ABBVIE DEFERRED COMPENSATION PLAN (Amended and Restated Effective as of January 1, 2017) ABBVIE DEFERRED COMPENSATION PLAN ARTICLE I INTRODUCTION (Filed With SEC on February 17, 2017)

ABBVIE SUPPLEMENTAL PENSION PLAN (Amended and Restated Effective as of January 1, 2016) ABBVIE SUPPLEMENTAL PENSION PLAN SECTION 1 INTRODUCTION (Filed With SEC on February 17, 2017)

ABBVIE INC. 1,400,000,000 0.375% Senior Notes due 2019 1,450,000,000 1.375% Senior Notes due 2024 750,000,000 2.125% Senior Notes due 2028 UNDERWRITING AGREEMENT (Filed With SEC on November 17, 2016)

ABBVIE INC. SUPPLEMENTAL INDENTURE NO. 4 1,400,000,000 0.375% Senior Notes due 2019 1,450,000,000 1.375% Senior Notes due 2024 750,000,000 2.125% Senior Notes due 2028 (Filed With SEC on November 17, 2016)

DATED NOVEMBER 17, 2016 ISSUER PAYING AGENT TRANSFER AGENT REGISTRAR - AND - TRUSTEE AGENCY AGREEMENT relating to Notes issued under a prospectus dated April 27, 2015, as... (Filed With SEC on November 17, 2016)

AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER (Filed With SEC on June 1, 2016)

ABBVIE INC. $1,800,000,000 2.300% Senior Notes due 2021 $1,000,000,000 2.850% Senior Notes due 2023 $2,000,000,000 3.200% Senior Notes due 2026 $1,000,000,000 4.300% Senior Notes... (Filed With SEC on May 12, 2016)

ABBVIE INC. SUPPLEMENTAL INDENTURE NO. 3 $1,800,000,000 2.300% Senior Notes due 2021 $1,000,000,000 2.850% Senior Notes due 2023 $2,000,000,000 3.200% Senior Notes due 2026... (Filed With SEC on May 12, 2016)

ABBVIE INC. NON-EMPLOYEE DIRECTOR RESTRICTED STOCK UNIT AGREEMENT (Filed With SEC on May 6, 2016)

ABBVIE INC. NON-QUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on May 6, 2016)

ABBVIE INC. RESTRICTED STOCK UNIT AGREEMENT (Filed With SEC on May 6, 2016)

ABBVIE INC. RESTRICTED STOCK AGREEMENT (Filed With SEC on May 6, 2016)

ABBVIE INC. PERFORMANCE SHARE AWARD AGREEMENT (Filed With SEC on May 6, 2016)

ABBVIE INC. PERFORMANCE-VESTED RESTRICTED STOCK UNIT AGREEMENT (Filed With SEC on May 6, 2016)

AGREEMENT AND PLAN OF MERGER Dated as of April 25, 2016 by and among STEMCENTRX, INC., ABBVIE INC., SIRIUS SONOMA CORPORATION, SIRIUS SONOMA LLC and, solely for the purposes set... (Filed With SEC on May 6, 2016)

ABBVIE PERFORMANCE INCENTIVE PLAN (Amended and Restated Effective as of January 1, 2015) (Filed With SEC on February 19, 2016)

ABBVIE DEFERRED COMPENSATION PLAN (Amended and Restated Effective as of January 1, 2015) (Filed With SEC on February 19, 2016)

ABBVIE NON-EMPLOYEE DIRECTORS FEE PLAN (Amended and Restated Effective as of May 6, 2016) (Filed With SEC on February 19, 2016)

ABBVIE SUPPLEMENTAL SAVINGS PLAN (Amended and Restated Effective as of January 1, 2015) (Filed With SEC on February 19, 2016)

$2,000,000,000 THREE-YEAR TERM LOAN CREDIT AGREEMENT Dated as of September 25, 2015 among ABBVIE INC., as Borrower, VARIOUS FINANCIAL INSTITUTIONS, as Lenders, and BANK OF... (Filed With SEC on September 29, 2015)

$2,000,000,000 364-DAY TERM LOAN CREDIT AGREEMENT Dated as of September 25, 2015 among ABBVIE INC., as Borrower, VARIOUS FINANCIAL INSTITUTIONS, as Lenders, and BANK OF AMERICA,... (Filed With SEC on September 29, 2015)

ABBVIE INC. SUPPLEMENTAL INDENTURE NO. 2 $3,000,000,000 1.800% Senior Notes due 2018 $3,750,000,000 2.500% Senior Notes due 2020 $1,000,000,000 3.200% Senior Notes due 2022... (Filed With SEC on May 14, 2015)

ABBVIE INC. $3,000,000,000 1.800% Notes due 2018 $3,750,000,000 2.500% Notes due 2020 $1,000,000,000 3.200% Notes due 2022 $3,750,000,000 3.600% Notes due 2025 $2,500,000,000... (Filed With SEC on May 7, 2015)

$18,000,000,000 364DAY BRIDGE TERM LOAN CREDIT AGREEMENT Dated as of March 27, 2015 among ABBVIE INC., as Borrower, VARIOUS FINANCIAL INSTITUTIONS, as Lenders, and MORGAN STANLEY... (Filed With SEC on March 30, 2015)

AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF REORGANIZATION (Filed With SEC on March 23, 2015)

AMENDMENT NO. 1 TO REVOLVING CREDIT AGREEMENT (Filed With SEC on March 20, 2015)

AGREEMENT AND PLAN OF REORGANIZATION by and among ABBVIE INC., OXFORD AMHERST CORPORATION, OXFORD AMHERST LLC and PHARMACYCLICS, INC. dated as of March 4, 2015 (Filed With SEC on March 6, 2015)

SUPPORT AGREEMENT (Filed With SEC on March 6, 2015)

20 October 2014 ABBVIE INC. and SHIRE PLC TERMINATION AGREEMENT Herbert Smith Freehills LLP 1 (Filed With SEC on October 21, 2014)

3,200,000,000 TERM LOAN CREDIT AGREEMENT Dated as of August 18, 2014 among ABBVIE HOLDINGS PRIVATE LIMITED, as Borrower, the GUARANTORS party hereto, VARIOUS FINANCIAL... (Filed With SEC on August 21, 2014)

$4,000,000,000 REVOLVING CREDIT AGREEMENT Dated as of August 18, 2014 among ABBVIE INC. and ABBVIE PRIVATE LIMITED, as Borrowers, the GUARANTOR party hereto, VARIOUS FINANCIAL... (Filed With SEC on August 21, 2014)

AMENDMENT NO. 1 TO 364-DAY BRIDGE CREDIT AGREEMENT August 11, 2014 (Filed With SEC on August 21, 2014)

RECOMMENDED COMBINATION OF SHIRE PLC AND ABBVIE INC. (Filed With SEC on July 18, 2014)

18 July 2014 ABBVIE INC and SHIRE PLC CO-OPERATION AGREEMENT Herbert Smith Freehills LLP 1 (Filed With SEC on July 18, 2014)

13,500,000,000 364-DAY BRIDGE CREDIT AGREEMENT Dated as of July 17, 2014 among ABBVIE PRIVATE LIMITED, as Borrower, the GUARANTORS party hereto, VARIOUS FINANCIAL INSTITUTIONS, as... (Filed With SEC on July 18, 2014)

FIRST AMENDMENT TO INTERNATIONAL COMMERCIAL OPERATIONS AGREEMENT (Filed With SEC on February 21, 2014)

FIRST AMENDMENT TO LUXEMBOURG INTERNATIONAL COMMERCIAL OPERATIONS AGREEMENT (Filed With SEC on February 21, 2014)

ABBVIE INC. NON-EMPLOYEE DIRECTOR RESTRICTED STOCK UNIT AGREEMENT (Filed With SEC on May 8, 2013)

ABBVIE INC. NON-EMPLOYEE DIRECTOR NON-QUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on May 8, 2013)

ABBVIE INC. PERFORMANCE RESTRICTED STOCK AGREEMENT (Filed With SEC on May 8, 2013)

ABBVIE INC. NON-QUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on May 8, 2013)

ABBVIE INC. NON-QUALIFIED REPLACEMENT STOCK OPTION AGREEMENT (Filed With SEC on May 8, 2013)

ABBVIE 2013 MANAGEMENT INCENTIVE PLAN (Effective as of January 1, 2013 and conformed through the First Amendment) (Filed With SEC on March 15, 2013)

ABBVIE 2013 PERFORMANCE INCENTIVE PLAN (Effective as of January 1, 2013) (Filed With SEC on March 15, 2013)

ABBVIE DEFERRED COMPENSATION PLAN (Effective as of January 1, 2013) (Filed With SEC on March 15, 2013)

ABBVIE NON-EMPLOYEE DIRECTORS FEE PLAN (Effective as of January 1, 2013) (Filed With SEC on March 15, 2013)

ABBVIE SUPPLEMENTAL PENSION PLAN (Effective as of January 1, 2013) (Filed With SEC on March 15, 2013)

ABBVIE SUPPLEMENTAL SAVINGS PLAN (Effective as of January 1, 2013) (Filed With SEC on March 15, 2013)

U.S. TRANSITION SERVICES AGREEMENT BY AND BETWEEN ABBOTT LABORATORIES AND ABBVIE INC. DATED AS OF DECEMBER 31, 2012 (Filed With SEC on January 2, 2013)

EX-U.S. TRANSITION SERVICES AGREEMENT BY AND BETWEEN ABBOTT LABORATORIES AND ABBVIE INC. DATED AS OF DECEMBER 31, 2012 (Filed With SEC on January 2, 2013)

TAX SHARING AGREEMENT Between ABBOTT LABORATORIES on behalf of itself and the ABBOTT AFFILIATES and ABBVIE INC. on behalf of itself and the ABBVIE AFFILIATES (Filed With SEC on January 2, 2013)

Category

Industry

Companies

Contracts

AbbVie Inc. Contracts & Agreements